ArticleInternational journal of oncology2023

Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.

Laijian Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.